NCT03685721View on ClinicalTrials.gov

Genotype -Phenotype Correlation of PKLR Variants With Pyruvate Kinase, 2,3-Diphosphglycerate and Adenosine Triphosphate Activities in Red Blood Cells of People With Sickle Cell Disease

RecruitingOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

October 11, 2018

Primary Completion Date

July 1, 2026

Study Completion Date

July 1, 2026

Conditions
Sickle CellPKLR VariantsAdenosine Triphosphate Activities
Trial Locations (1)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT03685721 - Genotype -Phenotype Correlation of PKLR Variants With Pyruvate Kinase, 2,3-Diphosphglycerate and Adenosine Triphosphate Activities in Red Blood Cells of People With Sickle Cell Disease | Biotech Hunter | Biotech Hunter